[HTML][HTML] Drug repurposing for the treatment of bacterial and fungal infections
A Miró-Canturri, R Ayerbe-Algaba… - Frontiers in microbiology, 2019 - frontiersin.org
Multidrug-resistant (MDR) pathogens pose a well-recognized global health threat that
demands effective solutions; the situation is deemed a global priority by the World Health …
demands effective solutions; the situation is deemed a global priority by the World Health …
New horizons for old drugs and drug leads
GM Cragg, PG Grothaus… - Journal of natural products, 2014 - ACS Publications
There is mounting urgency to find new drugs for the treatment of serious infectious diseases
and cancer that are rapidly developing resistance to previously effective drugs. One …
and cancer that are rapidly developing resistance to previously effective drugs. One …
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
In response to the current global health emergency posed by the Zika virus (ZIKV) outbreak
and its link to microcephaly and other neurological conditions, we performed a drug …
and its link to microcephaly and other neurological conditions, we performed a drug …
[HTML][HTML] Early state research on antifungal natural products
Nosocomial infections caused by fungi have increased greatly in recent years, mainly due to
the rising number of immunocompromised patients. However, the available antifungal …
the rising number of immunocompromised patients. However, the available antifungal …
[HTML][HTML] Emerging therapies targeting the ubiquitin proteasome system in cancer
NM Weathington, RK Mallampalli - The Journal of clinical …, 2014 - Am Soc Clin Investig
The ubiquitin proteasome system (UPS) is an essential metabolic constituent of cellular
physiology that tightly regulates cellular protein concentrations with specificity and precision …
physiology that tightly regulates cellular protein concentrations with specificity and precision …
[HTML][HTML] Antifungal drug repurposing
JH Kim, LW Cheng, KL Chan, CC Tam, N Mahoney… - Antibiotics, 2020 - mdpi.com
Control of fungal pathogens is increasingly problematic due to the limited number of
effective drugs available for antifungal therapy. Conventional antifungal drugs could also …
effective drugs available for antifungal therapy. Conventional antifungal drugs could also …
Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi
JA Parente-Rocha, AM Bailão… - Mediators of …, 2017 - Wiley Online Library
Diseases caused by fungi can occur in healthy people, but immunocompromised patients
are the major risk group for invasive fungal infections. Cases of fungal resistance and the …
are the major risk group for invasive fungal infections. Cases of fungal resistance and the …
Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria
Current antimicrobial susceptibility testing has limited screening capability for identifying
empirical antibiotic combinations to treat severe bacterial infections with multidrug-resistant …
empirical antibiotic combinations to treat severe bacterial infections with multidrug-resistant …
The NCATS Pharmaceutical Collection: a 10-year update
HighlightsNPC repurposing screens discovered compounds with new clinical
indications.Systematic NPC screening data establishes rich drug activity …
indications.Systematic NPC screening data establishes rich drug activity …
An update on the global treatment of invasive fungal infections
ME Munzen, AD Goncalves Garcia… - Future …, 2023 - Taylor & Francis
Fungal infections are a serious problem affecting many people worldwide, creating critical
economic and medical consequences. Fungi are ubiquitous and can cause invasive …
economic and medical consequences. Fungi are ubiquitous and can cause invasive …